Skip to content

Depression research published in 2025

Page 35 of 39: studies 681 to 700 of 761, newest first. Back to the depression overview

Studies

Psilocybin for Depression and Anxiety in Cancer Patients

2025 Tammie E. Quest, Ali John Zarrabi

Abstract Fifty-one cancer patients with symptoms of depression and anxiety were enrolled in a randomized, double-blind, crossover trial using low-dose psilocybin (placebo) and high-dose psilocybin (intervention group) combined with psychotherapy with 5 weeks between dosing sessions and at 6-month follow-up. Participants in the intervention group had large decreases in clinician- and self-rated...

The perspectives of patients with depression toward esketamine, and the influence of their medication adherence on their viewpoints: a Saudi cross-sectional study.

Frontiers in Psychiatry 2025 Ahmad H Almadani, Ayedh H Alghamdi, Fahad B Alfahad et al.

Nasal esketamine has demonstrated efficacy in the management of treatment-resistant depression and psychiatric emergency due to major depression. This study investigates acceptance and awareness of esketamine as a depression treatment option, focusing on factors that influence patients' acceptance, including adherence to current medication regimens, regardless of prior esketamine exposure. This...

Comparative safety and tolerability of ketamine and esketamine for major depressive disorder: a systematic review and meta-analysis.

Frontiers in Pharmacology 2025 Haoning Guo, Liling Tang, Miaoquan He et al. 5 citations

Ketamine and esketamine have demonstrated rapid, short-term antidepressant effects in major depressive disorder (MDD), but their relative safety remains unclear. This review aims to update the evidence on the safety of two agents for MDD and indirectly compare their safety and tolerability. We systematically searched PubMed, PsycINFO, Embase, and Cochrane databases up to 1 May 2025. Eligible...

Association between S-ketamine induced changes in glutamate levels in the pregenual anterior cingulate cortex and plasma brain-derived neurotrophic factor in healthy subjects.

Frontiers in Psychiatry 2025 Leonard Marx, Zümrüt Duygu Sen, Lena Vera Danyeli et al.

Ketamine's antidepressant effects have been linked to its modulation of glutamatergic neurotransmission and synaptic plasticity. However, the precise roles of both glutamate (Glu) levels and brain-derived neurotrophic factor (BDNF) in this process remain incompletely understood. This study examined the relationship between ketamine-induced changes in Glu levels and peripheral BDNF levels using...

DOI: 10.3389/fpsyt.2025.1662051 (opens in new tab) Full text (opens in new tab) Anterior cingulate cortex Brain-derived neurotrophic factor Magnetic resonance spectroscopy Ketamine antidepressant ketamine +8

Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis.

Therapeutic Advances in Psychopharmacology 2025 Ahmed Elmosalamy, Idil Tarikogullari, Liliana Patarroyo-Rodriguez et al. 7 citations

Depression affects approximately 5.7% of adults worldwide, and around one-third of these individuals develop treatment-resistant depression (TRD). Intravenous (IV) ketamine and esketamine (administered IV or intranasally (IN)) are novel treatment options for TRD; however, only IN esketamine currently holds FDA approval. Compare the acute effectiveness of IV ketamine with esketamine (IV or IN)...

Ketamine dosing formula in treatment-resistant bipolar depression.

Therapeutic Advances in Psychopharmacology 2025 Aleksander Kwaśny, Wiesław Jerzy Cubała, Alina Wilkowska

Intravenous ketamine is effective in treatment-resistant bipolar depression (TRBD) with dosing typically based on actual body weight (ABW). This study examined whether alternative normalization formulas are associated with treatment response. A retrospective exploratory analysis of a naturalistic registry for short-term ketamine use. A total of 22 TRBD inpatients received short-term intravenous...

DOI: 10.1177/20451253251392817 (opens in new tab) Full text (opens in new tab) Body surface area Ideal body weight Lean body mass Treatment-resistant bipolar depression +7

Low-dose intravenous esketamine on a depressive catatonia patient with venous thromboembolism: a case report.

Frontiers in Psychiatry 2025 Meng-Han Zhang, Yi-Fan Wang, Juan Li et al.

Catatonia is a rare but potentially life-threatening psycho-motor syndrome. It is mainly manifested as decreased activities, or excessive and specific activities, such as stupor, agitation and defiance. Catatonia can appear in various diseases and the diagnosis and treatment of depressive catatonia are often delayed. As an N-methyl-D-aspartate (NMDA) receptor antagonist, esketamine shows...

DOI: 10.3389/fpsyt.2025.1688633 (opens in new tab) Full text (opens in new tab) Major depressive disorder N-methyl-d-aspartate receptor antagonist Venousthromboembolism Catatonia treatment +1

Dreams and Nightmares in Early Pregnancy: A Comparative Study with a Control Group.

Nature and Science of Sleep 2025 Serena Scarpelli, Marta Spinoni, Maurizio Gorgoni et al. 1 citation

This study investigated dream characteristics in women during the first trimester of pregnancy compared to a group of non-pregnant women, aiming to identify variables associated with the observed differences. A sample of 100 pregnant women in their first trimester was compared to a control group of 100 age-matched non-pregnant women. Participants completed online questionnaires to assess dream...

DOI: 10.2147/NSS.S520737 (opens in new tab) Full text (opens in new tab) Depression Continuity hypothesis First trimester Gestation +2

Antidepressant and anxiolytic effects of activating 5HT2A receptors in the anterior cingulate cortex and the theoretical mechanisms underlying them - A scoping review of available literature.

Brain Research 2025 Leonor Miranda 59 citations

Psychedelic drugs that activate the 5HT2A receptor have long been the target of extensive clinical research, particularly in models of psychiatric illness. The aim of this literature review was to investigate the therapeutic effects of 5HT2A receptor activation in the anterior cingulate cortex (ACC) and the respective mechanisms that underlie them. Based on the available research, I suggest...

The role of emotion regulation through mindfulness in oncological patients: A pilot study.

Journal of Psychosocial Oncology 2025 Carmen Yélamos Agua, Sofía Luque Suárez, María Ruesga García et al. 1 citation

Traditional MBSR or MBTC programs do not delve deeply enough into emotional regulation, which is especially relevant in oncological patients. The aim of this study was to analyze the benefits of a mindfulness-based emotion regulation program in adult oncological patients. Psycho-oncologists from the AECC developed a mindfulness-based emotion regulation program. The Five Facet Mindfulness...

What Do We Know About the Validity and Reliability of Mindfulness Self-Report Measures in Persons with Dementia? A Critical Narrative Review.

Clinical Gerontologist 2025 Philipp M Keune, Regina Meister, Jana Keune et al. 2 citations

Mindfulness-based interventions (MBIs) for persons with dementia (PwD) have yielded mixed results, possibly attributable to the fact that little is known about the validity and reliability of trait mindfulness self-report measures in PwD. This narrative review sought to identify studies involving self-reported trait mindfulness and other clinical measures that may hold information on the...

Mindfulness-Based Stress Reduction Program for reducing anxiety and depression in hospital staff during a pandemic: A randomized controlled trial.

Journal of Psychiatric Research 2025 Carolina Mariño-narvaez, Borja Romero-Gonzalez, Jose A Puertas-Gonzalez et al. 7 citations

Hospital staff have experienced an increase in psychopathological symptoms such as anxiety or depression during the COVID-19 pandemic. Thus, the aims of the present research were, firstly, to study the effectiveness of the Mindfulness-Based Stress Reduction Program in reducing psychopathological symptoms in hospital staff during the COVID-19 pandemic, as well as, its effectiveness in increasing...

Longitudinal analysis of the role of mindfulness on HIV stigma, depression, substance use and HIV outcomes among female sex workers living with HIV in the Dominican Republic.

AIDS Care 2025 Yan Wang, Carla J. Berg, Yeycy Donastorg et al. 2 citations

Female sex workers (FSW) living with HIV experience greater depression and worse HIV outcomes than people living with HIV (PLHIV) overall. Mindfulness is related to lower depression and higher ART adherence in PLHIV. Few studies have assessed these relationships among FSW, especially longitudinally. This study assessed the temporal relationship between mindfulness, mental health and HIV...

A physical activity and socioemotional intervention for residents of a large vulnerable community in Brazil during the COVID-19 pandemic: a randomized controlled study.

Frontiers in Public Health 2025 Mateus Torres-Cruz, Mariana Moura-Alves, Renata Pereira Lima et al. 1 citation

The COVID-19 pandemic exacerbated mental health issues, particularly in vulnerable communities. Non-psychiatric interventions, including psychological emotional regulation, contemplative practices, and physical activity, can be powerful tools for improving mental health, especially in vulnerable populations. The present study evaluates the effect of a novel low-cost Socioemotional and Physical...

Chatbot-Based Mindfulness-Based Stress Reduction Program for University Students With Depressive Symptoms: Intervention Development and Pilot Evaluation.

Journal of the American Psychiatric Nurses Association 2025 Yan Li, Tsz Yu Chung, Wenze Lu et al. 28 citations

Depression is a growing concern among university students. Chatbots provide flexible, accessible, personalized psychosocial support. Delivering Mindfulness-Based Stress Reduction (MBSR) sessions via chatbots may reduce depressive symptoms in university students. This study aims to evaluate the feasibility, acceptability, safety, and preliminary efficacy of a chatbot-based MBSR intervention for...

DOI: 10.1177/10783903241302092 (opens in new tab) Full text (opens in new tab) Depression Chatbot Intervention development Mindfulness-based stress reduction +2

The Mindful Compassion Program Integrated with Body-Mind-Spirit Empowerment for Reducing Depression in Lung Cancer Patient-Caregiver Dyads.

Psychosocial Intervention 2025 Fei-Hsiu Hsiao, Chao-Chi Ho, Chong-Jen Yu et al. 4 citations

Objective: This study compared the long-term effects of a mindful compassion program on improving depression in lung cancer patients, both in patient-caregiver dyads and in patient-only groups, and examined the moderating roles of anxiety and quality of life (QOL). Method: Participants consisted of 56 dyads, who were randomly assigned to either the dyadic or patient-only groups. Data collection...

DOI: 10.5093/pi2025a1 (opens in new tab) Full text (opens in new tab) Anxiety Depressive symptoms Dyadic depression program Mindfulness awareness +1

Childhood trauma and subclinical PTSD symptoms predict adverse effects and worse outcomes across two mindfulness-based programs for active depression.

PLoS One 2025 Nicholas K. Canby, Elizabeth A Cosby, Roman Palitsky et al. 10 citations

Within mindfulness-based programs (MBPs), mixed results have been found for the role of childhood trauma as a moderator of depression outcomes. Furthermore, childhood trauma and PTSD symptoms have been identified as possible risk factors for the occurrence of meditation-related adverse effects (MRAE). The present research examined multiple forms of childhood trauma and PTSD symptoms as...

Mindfulness-based (non-contact) boxing therapy (MBBT) for depression and anxiety: A feasibility study.

PLoS One 2025 Johny Bozdarov, Brett D. M. Jones, Madeha Umer et al. 2 citations

Mindfulness-Based (non-contact) Boxing Therapy (MBBT) is a novel intervention designed to empower and promote self-agency through behavioral interventions, while reducing barriers to exercise for individuals with mental disorders. MBBT is an instructor-led, manualized, non-contact boxing group-exercise program (delivered in 90 min sessions, twice a week, over 10 weeks) that blends principles of...

The Effect of Mindfulness-Based Cognitive Therapies on Sexual Function, Sexual Distress, and Depression in Women: A Meta-Analysis Study.

International journal of sexual health : official journal of the World Association for Sexual Health 2025 Ayşe Çuvadar, Handan Özcan 3 citations

Objective: This study was carried out to determine the effect of mindfulness-based cognitive therapies adapted for sexual function concerns on women's sexual function, sexual distress, and depression levels. Methods: For this meta-analysis study, a review was conducted by screening studies published in the last 10 years on PubMed, Web of Science, EBSCOhost, Google Scholar, and YÖK National...

DOI: 10.1080/19317611.2024.2414064 (opens in new tab) Full text (opens in new tab) Depression Sexual dysfunction Mindfulness-based cognitive therapy Sexual distress

Dispositional mindfulness profiles and psychological symptoms: a latent profile analysis.

Frontiers in Psychology 2025 Fereshteh Mehrabi, Shadi Beshai 3 citations

In this study, we aimed to (1) examine profiles of mindfulness using the short form of the FFMQ (FFMQ-SF), (2) identify the demographic predictor (i.e., sex) of mindfulness profile membership, and (3) examine associations of mindfulness profiles with psychological outcomes (i.e., anxiety and depressive symptoms). This cross-sectional study included 604 individuals recruited from Amazon's...

DOI: 10.3389/fpsyg.2025.1411901 (opens in new tab) Full text (opens in new tab) Anxiety Depression Five-facet mindfulness questionnaire Dispositional mindfulness +1